Komunikaty PR

Second Heart Assist's Whisper Device Poised to Advance AHA CKM Goals with Breakthrough Heart–Kidney Support

2025-08-15  |  23:55:05

Jeff Donofrio presenting Whisper at Octane's Annual Cario Tech Forum in Newport Beach, CA

Proven kidney perfusion, heart unloading, and low hemolysis in testing, Whisper sets a new standard in integrated care for heart failure and kidney disease.

The industry has been forced to choose between protecting the heart or the kidney. Whisper proves you can, and must, do both”
— Jeff Donofrio, CEO- Second Heart Assist
SALT LAKE CITY, CA, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- Second Heart Assist, Inc. is introducing its Whisper percutaneous mechanical circulatory support device as a potential new force in the fight against cardiovascular–kidney–metabolic (CKM) disease. Whisper is designed to enhance kidney perfusion while unloading the heart, supported by low hemolysis results in FDA-requested bench testing.

The American Heart Association (AHA) has declared CKM syndrome a public health emergency, with only 10% of U.S. adults meeting “excellent” CKM health standards. As the AHA expands its CKM initiative to 15 regions and 150 care sites, it is calling for earlier screening and integrated treatment that unites cardiology, nephrology, and metabolic care.

Whisper’s dual-organ approach was built to align with that vision.

Performance that benefits both heart and kidney
Many older-generation devices require extremely high rotational speeds to increase kidney flow, which can also raise red blood cell damage (hemolysis). Whisper is engineered for low-RPM performance and placed in the descending aorta just above the renal arteries. This position directs blood where the kidneys need it most while easing the heart’s workload.

“The industry has been forced to choose between protecting the heart or the kidney. Whisper proves you can, and must, do both,” said Jeff Donofrio, CEO of Second Heart Assist. “We have seen it in our international results and in our hemolysis data. Our focus is on delivering solutions that are fast to deploy, safe for patients, and effective where it matters most.”

Company-reported OUS results
• 28 patients treated outside the United States
• No device-related adverse events
• Average hospital stay of 48 hours
• Zero readmissions during the initial follow-up period
• Average deployment and initiation of treatment in under 2 minutes

Hemolysis advantage
In an FDA-requested in vitro study, Whisper showed approximately 50% less mechanical hemolysis than a comparator device (Impella) under identical conditions, operating at about 10,000 RPM versus more than 44,000 RPM required by the comparator to match flow.

Expert perspectives
Leslie W. Miller, MD, Chief Medical Officer, Second Heart Assist
“The CKM initiative will bring needed attention to the important dynamic interaction between the heart and kidney as heart failure triggers adverse responses in the kidneys that secondarily worsens kidney function and patients with intrinsic kidney impairment have a high incidence of secondary cardiac disease. The positioning of the SHA device provides simultaneous benefit to both the heart and kidneys by unloading the heart to increase cardiac output, and significantly increasing blood flow to the kidney to reverse the consequences of heart failure and stimulate the recovery of the function of both organs.

Rob Coronado, MD, Advisor, Second Heart Assist
“For patients with vulnerable kidneys, every moment of optimized perfusion matters. Whisper reflects the priorities of CKM care. It supports kidney health, protect the heart, and make the therapy simple, safe, and fast to deliver.”

Why this matters
Heart failure readmissions remain among the most frequent and costly events in U.S. healthcare and are often linked to kidney decline. The AHA’s CKM initiative emphasizes strategies that protect both organs to reduce complications, improve patient outcomes, and lower costs. Whisper’s engineering and early results position it as a powerful candidate for this integrated approach.

Next steps
Second Heart Assist is preparing to launch its U.S. Early Feasibility Study, building on OUS experience and published bench data, with the goal of helping health systems deliver on AHA CKM objectives in real-world care.

About Second Heart Assist
Second Heart Assist develops percutaneous and implantable circulatory support systems intended to improve hemodynamics while addressing kidney-relevant flow needs. The company’s U.S. patent portfolio includes U.S. Patent No. 11,602,627 and related international applications covering stent-cage pump configurations and renal-adjacent positioning concepts.

Adam Steelwater
Innovative Tech Capital Network
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire BRAK ZDJĘCIA
2025-08-16 | 00:55:14

Cardiac Registry Support Doubles its Network and Expands into Bariatric Surgery Registry Support Following Acquisition

Leading cardiac registry firm acquires Lynne Thompson Consulting LLC dba Quality Health Data to enhance offerings, extend expertise to MBSAQIP and obesity care BROOKLYN, NY, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- Cardiac Registry Support Doubles its Hospital Network and Expands into Bariatric Surgery Registry Support Following Strategic Acquisition Leading cardiac registry specialist firm acquires Lynne Thompson Consulting LLC dba Quality Health Data to enhance service offerings and extend expertise to MBSAQIP and obesity care programs RPAutomation Inc. dba Cardiac Registry Support (CRS), a premier provider of cardiac registry services, today announced the successful acquisition of Lynne Thompson Consulting/Quality Health Data, marking a significant expansion of its service portfolio and geographic reach to over 100 hospitals and clinical research organizations. The strategic acquisition enables CRS to double its hospital network while extending its proven registry management expertise into the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) and obesity care sectors. The acquisition represents a major milestone in CRS's growth trajectory, building upon the company's established reputation for excellence in cardiac registry support. With this expansion, CRS now serves twice as many healthcare facilities nationwide, providing comprehensive registry management solutions that drive quality improvement and regulatory compliance across multiple clinical specialties."This acquisition demonstrates our commitment to helping healthcare organizations achieve excellence in quality reporting and patient outcomes across all specialty areas," said Angela Teagle, President of Cardiac Registry Support. "By combining our deep expertise in cardiac registry management with Lynne Thompson Consulting's specialized knowledge in bariatric and metabolic surgery programs, we're creating an unparalleled resource for hospitals seeking to optimize their registry performance and quality metrics." The expanded CRS team brings together industry-leading expertise in multiple national registry programs, including extensive experience with MBSAQIP requirements and obesity care quality measures. This enhanced capability enables CRS to offer comprehensive, integrated registry solutions that address the increasingly complex needs of modern healthcare organizations. Key benefits of the expansion include: • Doubled Service Capacity: CRS now supports twice as many hospitals nationwide, demonstrating the scalability and effectiveness of its proven registry management approach • Expanded Clinical Expertise: Addition of specialized MBSAQIP and obesity care registry support to complement existing cardiac registry services • Enhanced Team Resources: Integration of Lynne Thompson Consulting's experienced professionals creates a stronger, more diverse team of registry experts • Comprehensive Quality Solutions: Ability to provide integrated registry support across multiple clinical departments within the same healthcare organization • Proven Track Record: Combined expertise representing decades of successful registry management and quality improvement initiatives. The expansion comes at a critical time as healthcare organizations face increasing pressure to demonstrate quality outcomes while managing complex regulatory requirements across multiple clinical programs. CRS's enhanced capabilities position the company to serve as a single, trusted partner for hospitals seeking to excel in registry reporting and quality improvement initiatives."Our cardiac registry clients have consistently achieved exceptional results, with improved data accuracy, enhanced compliance scores, and measurable quality improvements," added Teagle . "We're excited to bring this same level of excellence to bariatric surgery programs and obesity care initiatives, helping more healthcare organizations transform their registry data into actionable insights that improve patient care." The integrated team is already operational, with existing Lynne Thompson Consulting clients experiencing a seamless transition and immediate access to CRS's expanded resources and technological capabilities. New and prospective clients can now benefit from comprehensive registry solutions that span multiple clinical specialties, all delivered through a single, coordinated service partnership. About Cardiac Registry Support Cardiac Registry Support is a leading provider of registry management and quality improvement services for healthcare organizations nationwide. With proven expertise in cardiac, bariatric, and specialty registry programs, CRS helps hospitals and health systems optimize their registry performance, achieve accreditation requirements, and improve patient outcomes through data-driven insights and expert support. For more information about Cardiac Registry Support and its expanded service offerings, visit cardiacregistrysupport.com, or contact: Media Contact: vikrumm@cardiacregistrysupport.com
EIN Newswire BRAK ZDJĘCIA
2025-08-16 | 00:55:14

ECRA Partners with Mauritius Consultant to Pilot Global Early Childhood Quality Accreditation Framework

Soonita Kistamah joins forces with ECRA to pilot its five-tier accreditation framework in Mauritius, raising early years education standards. MAURITIUS, August 15, 2025 /EINPresswire.com/ -- Mauritius Education Consultant Collaborates with ECRA
EIN Newswire BRAK ZDJĘCIA
2025-08-16 | 00:55:14

Michael Fomkin Partners with Jack Canfield and SuccessBooks® as a Co-Author of 'Living Truth'

Michael FomkinNEWTON, PA, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- SuccessBooks® is thrilled to announce that Michael Fomkin will be featured as a co-author in the upcoming book “Living Truth”, alongside world-renowned

Więcej ważnych informacji

Jedynka Newserii

Jedynka Newserii

Kongres Profesjonalistów Public Relations

Konsument

Polacy nie korzystają z hossy trwającej na warszawskiej giełdzie. Na wzrostach zarabiają głównie inwestorzy zagraniczni

Od października 2022 roku na rynkach akcji trwa hossa, nie omija ona także warszawskiej giełdy. Mimo to inwestorzy indywidualni odpowiadają zaledwie za kilkanaście procent inwestycji, a o wzrostach decyduje i na nich zarabia głównie kapitał z zagranicy. Widać to również po napływach i odpływach do i z funduszy inwestycyjnych. Zdaniem Tomasza Koraba, prezesa EQUES Investment TFI, do przekonania Polaków do inwestowania na rodzimej giełdzie potrzeba zysków z akcji, informacji o tych zyskach docierającej do konsumentów oraz czasu.

Polityka

Obowiązek zapełniania magazynów gazu w UE przed sezonem zimowym ma zapewnić bezpieczeństwo dostaw. Wpłynie też na stabilizację cen

Unia Europejska przedłuży przepisy z 2022 roku dotyczące magazynowania gazu. Będą one obowiązywać do końca 2027 roku. Zobowiązują one państwa członkowskie do osiągnięcia określonego poziomu zapełnienia magazynów gazu przed sezonem zimowym. Magazyny gazu pokrywają 30 proc. zapotrzebowania Unii Europejskiej na niego w miesiącach zimowych. Nowe unijne przepisy mają zapewnić stabilne i przystępne cenowo dostawy.

Infrastruktura

Gminy zwlekają z uchwaleniem planów ogólnych zagospodarowania przestrzennego. Może to spowodować przesunięcie terminu ich wejścia w życie

Reforma systemu planowania i zagospodarowania przestrzennego rozpoczęła się we wrześniu 2023 roku wraz z wejściem w życie większości przepisów nowelizacji ustawy z 27 marca 2003 roku. Uwzględniono w niej plany ogólne gminy (POG) – nowe dokumenty planistyczne, za których przygotowanie mają odpowiadać samorządy. Rada Ministrów w kwietniu br. uchwaliła jednak ustawę o zmianie ustawy z 7 lipca 2023 roku, a jej celem jest zmiana terminu obowiązywania studiów uwarunkowań i kierunków zagospodarowania przestrzennego gmin na 30 czerwca 2026 roku. Wskazana data może nie być ostateczna z uwagi na to, że żadna z gmin nie uchwaliła jeszcze POG.

Partner serwisu

Instytut Monitorowania Mediów

Szkolenia

Akademia Newserii

Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a  także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.